Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.
Press releases published on April 3, 2025
Orion Oyj:n varsinaisen yhtiökokouksen päätökset 3.4.2025
GlobeNewswire
·
April 3, 2025
ORION OYJ PÖRSSITIEDOTE – YHTIÖKOKOUKSEN PÄÄTÖKSET 3.4.2025 KLO 16.20 Orion Oyj:n varsinaisen yhtiökokouksen päätökset 3.4.2025 Orion Oyj:n tänään pidetty varsinainen yhtiökokous: Vahvisti maksettavaksi osingoksi 1,64 …
Hapbee Announces Partnership with Gharieni Group To License and Distribute Hapbee’s Wellness Technology in Europe and The Middle East
GlobeNewswire
·
April 3, 2025
VANCOUVER, British Columbia, April 03, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies, Inc. (TSXV: HAPB) (OTCQB: HAPBF), the leader in bio-streaming wellness technology, has announced a strategic partnership with Gharieni Group, a leading international …
Vantive Chief Strategy Officer Joins Labviva Board
GlobeNewswire
·
April 3, 2025
BOSTON, April 03, 2025 (GLOBE NEWSWIRE) -- Labviva, the leading AI procurement platform for life sciences, today announced the appointment of Ben Daverman to its Board of Directors. Daverman brings decades of expertise in corporate strategy, healthcare …
Precision Optics Enters into Main Purchase Agreement with Top Tier Aerospace Customer and Expands Program Backlog to $6.6 Million
GlobeNewswire
·
April 3, 2025
$3.1 million of new orders received during the current calendar year $6.6 million customer program backlog expected to be delivered over next 12 months $3.9 million of additional commitments expected to be received for calendar 2026 GARDNER, Mass., April …
Resmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwl™, Now Available Across the US
GlobeNewswire
·
April 3, 2025
SAN DIEGO, April 03, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced its home sleep apnea test, NightOwl™, is now available across the …
Senti Bio to Showcase SENTI-202 Clinical Data and Novel Logic Gated Gene Circuit Mechanism of Action in Oral and Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2025
GlobeNewswire
·
April 3, 2025
SOUTH SAN FRANCISCO, Calif., April 03, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene …
SPARK NS Selects Eight Projects to Receive Aggregate Funding of Up to $16 Million to Advance Academic Discoveries in Parkinson’s Disease from the Lab to the Clinic
GlobeNewswire
·
April 3, 2025
MENLO PARK, Calif., April 03, 2025 (GLOBE NEWSWIRE) -- SPARK NS today announced the eight projects and principal investigators selected for the SPARK NS Translational Research Program, 2025 Cohort. Participation in a SPARK NS program cohort lasts two years …
Dogwood Therapeutics, Inc. Regains Nasdaq Compliance
GlobeNewswire
·
April 3, 2025
ATLANTA, April 03, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), a development-stage biopharmaceutical company focused on developing new medicines to treat pain and fatigue-related disorders today announced it believes …
Ernexa Therapeutics Closes New Funding Round
GlobeNewswire
·
April 3, 2025
CAMBRIDGE, Mass., April 03, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced that it has entered into a securities purchase …
Winstrol Steroids: Winstrol Benefits, Winstrol Side Effects, Winstrol Results & Buy Winstrol Pills Alternatives Win-Max By CrazyBulk
GlobeNewswire
·
April 3, 2025
NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- “We’ve got several pro bodybuilding athletes ready and waiting to get to know you in our free private CrazyBulk community. And you’ll receive an invite to it the minute you purchase any CrazyBulk product. These …
Globus Medical completes acquisition of Nevro Corp.
GlobeNewswire
·
April 3, 2025
AUDUBON, Pa., April 03, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed acquisition of Nevro Corp., a global medical device company that is …
Autonomix Medical, Inc. to Highlight Technology and Early Proof-of-Concept Study Results in a Poster Presentation at the 2025 European Conference on Interventional Oncology (ECIO)
GlobeNewswire
·
April 3, 2025
THE WOODLANDS, TX, April 03, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision nerve-targeted treatments, today announced an abstract detailing its …
NewGen Secures Strategic Funding to Drive International Expansion and Corporate Growth
GlobeNewswire
·
April 3, 2025
BANGKOK, April 03, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that …
Scienture Holdings, Inc. Issues Annual Letter to Shareholders
GlobeNewswire
·
April 3, 2025
TAMPA, FL, April 03, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through …
Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor
GlobeNewswire
·
April 3, 2025
RUTHERFORD, N.J. and STOCKHOLM, April 03, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced an …
Elutia to Participate in Upcoming Investor Conferences
GlobeNewswire
·
April 3, 2025
SILVER SPRING, Md., April 03, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix technologies, today announced that Dr. Randy Mills, President and Chief Executive Officer, and Matt Ferguson, Chief Financial …
Phathom Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
April 3, 2025
FLORHAM PARK, N.J., April 03, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today that members of …
BetterLife Pharma Appoints Corporate Advisor
GlobeNewswire
·
April 3, 2025
VANCOUVER, British Columbia, April 03, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company, has announced that it has appointed André Beaudry as Corporate …
Extendicare Announces Timing of 2025 First Quarter Results and Conference Call
GlobeNewswire
·
April 3, 2025
MARKHAM, Ontario, April 03, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the first quarter of 2025 after market close on Tuesday, May 6, 2025. A …
Neurona Therapeutics Raises $102 Million to Fuel NRTX-1001 Phase 3 EPIC Epilepsy Trial and Advance Regenerative Cell Therapy Pipeline
GlobeNewswire
·
April 3, 2025
- The oversubscribed private financing round, with primary participation from Fidelity Management …